Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02861820 · ClinicalTrials.gov registry record
Functional Connectivity Changes During Early Recovery as a Marker for Relapse
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 160
- Enrollment target
NCT02861820: Completed study, sponsored by University of Minnesota.
NCT02861820 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 160 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02861820 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 160 participants
- Enrollment target
Study Summary
The study purpose is to examine whether there are structural or functional differences in the brains of individuals who use cocaine or amphetamines as opposed to control participants who have never used cocaine or amphetamines. More specifically, it will allow the investigator to see how the brain changes once people get sober and how those changes relate to successful recovery. This study will allow the investigator to examine the interaction between cocaine/amphetamines and impulsivity (meaning to act on impulse rather than thought). Results from this study will inform new biologically-based interventions to compliment existing treatment programs, in the hope of leading the field in a new direction.
Primary Outcome
3T MRI scan
Interventions
- DEVICE MRI: Brain Imaging Data Collection
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 160 participants |
| Start Date | 2015-07-01 |
| Est. Completion | 2021-01-26 |
What the finished NCT02861820 record still lists
NCT02861820 is an observational study that tracks outcomes without assigning an intervention. The registered 160 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which MRI: Brain Imaging Data Collection is the first listed.
NCT02861820 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02861820 about?
NCT02861820 is a clinical study titled "Functional Connectivity Changes During Early Recovery as a Marker for Relapse". The study purpose is to examine whether there are structural or functional differences in the brains of individuals who use cocaine or amphetamines as opposed to control participants who have never used cocaine or amphetamines. More specifically, it will allow the investigator to see how the brain c...
What is the current status of trial NCT02861820?
This trial is currently completed. The enrollment target is 160 participants. The study started on 2015-07-01. Estimated completion is 2021-01-26.
What interventions are being tested in trial NCT02861820?
The interventions under investigation include: MRI: Brain Imaging Data Collection (DEVICE).
Who is sponsoring clinical trial NCT02861820?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00501826 · 160 participants · Phase 2
Combination Chemotherapy and Nelarabine in Treating Patients With T-cell Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma
- NCT00932139 · 160 participants · NA
Effect of Electro-Acupuncture on Blood Pressure
- NCT00992901 · 160 participants · Early Phase 1
Role of Neural and Hormonal Regulation Factors on Insulin Secretion After Gastric Bypass Surgery
- NCT01515527 · 160 participants · Phase 2
Cladribine Plus Low Dose Cytarabine (LDAC) Alternating With Decitabine in Patients With Acute Myeloid Leukemia (AML) or High-Risk Myelodysplastic Syndrome (MDS)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI